Tracking cognitive decline at home using sensors
Automatic Assessment of Neuropsychiatric Symptoms at Home Predictive of Mental Health and Cognitive Disorders Using Non-Intrusive Ambient Intelligence Technologies
Stanford University · NCT06704971
This study is testing if in-home sensors can help track daily activities and mood changes in people with mild cognitive impairment and dementia to better understand their cognitive decline.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 25 (estimated) |
| Ages | 65 Years and up |
| Sex | All |
| Sponsor | Stanford University (other) |
| Locations | 1 site (Palo Alto, California) |
| Trial ID | NCT06704971 on ClinicalTrials.gov |
What this trial studies
This observational study aims to monitor neuropsychiatric symptoms in individuals with mild cognitive impairment and dementia by utilizing in-home sensors. Participants will have a small camera installed in their living space to collect data on daily activities over a period of 7 to 30 days. Alongside this, participants and their caregivers will complete regular surveys regarding mood and functioning. The collected data will be analyzed to identify patterns that correlate with behavioral assessments, aiding in accurate diagnosis and monitoring of cognitive decline.
Who should consider this trial
Good fit: Ideal candidates include individuals aged 65 and older, with or without mild to moderate dementia, and those who have a study partner available for regular communication.
Not a fit: Patients with severe mobility impairments or those residing in non-home settings, such as skilled nursing facilities, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more accurate and unobtrusive method for tracking cognitive decline, leading to better diagnosis and management of dementia-related conditions.
How similar studies have performed: While similar approaches have been explored, this specific methodology of using in-home sensors for tracking cognitive decline is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Age 65+ years old * Any age and ethnicity. * With or without, or at risk of mild to moderate dementia and healthy controls. * Availability of a study partner (informant) who has contact with the patient at least once a week (this can also be the surrogate/LAR but does not necessarily have to be) Exclusion criteria: * Those with severe mobility impairments * participants in non-home settings (skilled nursing facilities, etc.).
Where this trial is running
Palo Alto, California
- Clinical Excellence Research Center — Palo Alto, California, United States (RECRUITING)
Study contacts
- Principal investigator: Ehsan Adeli, PhD — Stanford University
- Study coordinator: NPS Study Team, PhD
- Email: npsresearchstudy@stanford.edu
- Phone: 650-498-0616
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Mild Cognitive Impairment, Mild Dementia, Dementia Alzheimers, Dementia, Memory Impairment, NPS